Research project
Evaluation of patient preferences for and cost effectiveness of community intravenous antibiotic services (CIVAS)
- Start date: -
- End date: -
- Partners and collaborators: Funding: National Institute for Health Research (NIHR) Health Services and Delivery Research (HS&DR)
- Co-investigators: Czoski-Murray (Leeds Institute of Health Sciences), Meads (Leeds Institute of Health Sciences), Hess (Institute of Transport Studies), Vargas-Palacios (Leeds Institute of Health Sciences), Mitchell (Leeds Institute of Health Sciences), Wright (Leeds Institute of Health Sciences), Hulme (Leeds Institute of Health Sciences), Raynor (School of Healthcare), McLintock (Leeds Institute of Health Sciences), Twiddy (Leeds Institute of Health Sciences)
- External co-investigators: Minton (Leeds Teaching Hospitals NHS Acute Trust), Gregson (Leeds Community Healthcare Trust), Stanley (Bradford Teaching Hospitals NHS Foundation Trust), Vincent (Leeds Teaching Hospitals NHS Acute Trust)
Description
Aims
1. Establish the types of Outpatient Parenteral Antimicrobial Therapy (OPAT) services available in England and identify barriers to the use of each service type
2. Evaluate patients’ preferences for different service models of delivering OPAT
3. Assess the cost-effectiveness of different service models of delivering OPAT
Method
Using a mixed methods approach the study included 7 centres providing OPAT and covering 4 main service models: hospital attendance, specialised nurse visiting at home, general nurse visiting at home, self or carer administration. The methods were:
- Systematic review
- Survey of health professionals
- Qualitative study of patient perceptions
- Quantitative analysis of patient preferences
- Cost effectiveness study
- Expert panel
Background
Intravenous (IV) antibiotic treatment was developed for patients in hospital, but for some years it has been accepted practice in most developed countries to provide this for patients living in the community, known as Outpatient Parenteral Antimicrobial Therapy (OPAT). There is evidence that it is safe, generally welcomed by patients and that there are opportunities for improved cost-effectiveness and increasing hospital capacity. However, OPAT has been slow to become established in the UK, with service provision being limited to clinical providers with effective, enthusiastic champions delivering a variety of different models of care. There is limited evidence available for NHS health care providers and commissioners to facilitate service development.
People
Minton, Leeds Teaching Hospitals NHS Acute Trust
Czoski-Murray, Leeds Institute of Health Sciences, University of Leeds
Meads, Leeds Institute of Health Sciences, University of Leeds
Hess, Institute of Transport Studies, University of Leeds
Vargas-Palacios, Leeds Institute of Health Sciences, University of Leeds
Mitchell, Leeds Institute of Health Sciences, University of Leeds
Wright, Leeds Institute of Health Sciences, University of Leeds
Hulme, Leeds Institute of Health Sciences, University of Leeds
Raynor, School of Healthcare, University of Leeds
Gregson, Leeds Community Healthcare Trust
Stanley, Bradford Teaching Hospitals NHS Foundation Trust
McLintock, Leeds Institute of Health Sciences, University of Leeds
Vincent, Leeds Teaching Hospitals NHS Acute Trust
Twiddy, Leeds Institute of Health Sciences, University of Leeds
Funding body
NIHR HS & DR
Contact
Prof DK Theo Raynor d.k.raynor@leeds.ac.uk